Yes, I realize their financials read like most other exploration plays. From OTC Markets;
Financial Reporting/Disclosure Reporting Status U.S. Reporting: SEC Filer Audited Financials Audited Latest Report Not Available Regulatory Agency Not Available CIK 0001387522 Fiscal Year End 10/31 OTC Market Tier OTCQB
I always viewed toxic financing as debt converted to shares at fractions of the current share price.
The conv debt here has conversion prices of .10-.16, with no clauses to lower the convertible rate.
On October 26, 2009, the Company issued 12% convertible notes to two investors with an aggregate face value of $20,000. The principal amount of the notes and interest is payable on October 26, 2011. While the note is outstanding, the investor has the option to convert the principal balance and interest, into common stock at a fixed conversion price of $0.10.